Engineering and Characterization of an Artificial Drug-Carrying Vesicles Nanoplatform for Enhanced Specifically Targeted Therapy of Glioblastoma

Scientists developed an engineered artificial vesicles (EAVs), ANG-TRP-PK1@EAVs, which were constructed using a liposome extruder from HEK293T cells expressing ANG-TRP-PK1 peptides.